Koch et al., 2011 - Google Patents
Proper synaptic vesicle formation and neuronal network activity critically rely on syndapin IKoch et al., 2011
View HTML- Document ID
- 3414345243986684258
- Author
- Koch D
- Spiwoks‐Becker I
- Sabanov V
- Sinning A
- Dugladze T
- Stellmacher A
- Ahuja R
- Grimm J
- Schüler S
- Müller A
- Angenstein F
- Ahmed T
- Diesler A
- Moser M
- Spessert R
- Boeckers T
- Fässler R
- Hübner C
- Balschun D
- Gloveli T
- Kessels M
- Qualmann B
- et al.
- Publication year
- Publication venue
- The EMBO journal
External Links
Snippet
Synaptic transmission relies on effective and accurate compensatory endocytosis. F‐BAR proteins may serve as membrane curvature sensors and/or inducers and thereby support membrane remodelling processes; yet, their in vivo functions urgently await disclosure. We …
- 101710044886 PACSIN1 0 title abstract description 199
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Koch et al. | Proper synaptic vesicle formation and neuronal network activity critically rely on syndapin I | |
| Lester et al. | Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components | |
| Charbonnier et al. | Functional reprogramming of regulatory T cells in the absence of Foxp3 | |
| Low et al. | Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease | |
| Szado et al. | Phosphorylation of inositol 1, 4, 5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis | |
| Sun et al. | UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity | |
| Hussain et al. | CDK6 associates with the centrosome during mitosis and is mutated in a large Pakistani family with primary microcephaly | |
| Huang et al. | BDNF-dependent recycling facilitates TrkB translocation to postsynaptic density during LTP via a Rab11-dependent pathway | |
| Gulyás-Kovács et al. | Munc18-1: sequential interactions with the fusion machinery stimulate vesicle docking and priming | |
| Espana et al. | β-Amyloid disrupts activity-dependent gene transcription required for memory through the CREB coactivator CRTC1 | |
| Edwards et al. | Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice | |
| Ageta-Ishihara et al. | Control of cortical axon elongation by a GABA-driven Ca2+/calmodulin-dependent protein kinase cascade | |
| Miyamoto et al. | Akt and PP2A reciprocally regulate the guanine nucleotide exchange factor Dock6 to control axon growth of sensory neurons | |
| Lin et al. | Abl2/Arg controls dendritic spine and dendrite arbor stability via distinct cytoskeletal control pathways | |
| Ren et al. | Selective histone deacetylase 6 inhibition normalizes B cell activation and germinal center formation in a model of systemic lupus erythematosus | |
| Lian et al. | Filamin a regulates neural progenitor proliferation and cortical size through Wee1-dependent Cdk1 phosphorylation | |
| Johnson et al. | Munc13-4 is a Rab11-binding protein that regulates Rab11-positive vesicle trafficking and docking at the plasma membrane | |
| Gispert et al. | Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression | |
| Holland et al. | LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis | |
| Stevenson et al. | Essential role of Elmo1 in Dock2-dependent lymphocyte migration | |
| Gu et al. | The BAD-BAX-caspase-3 cascade modulates synaptic vesicle pools via autophagy | |
| Brace et al. | SkpA restrains synaptic terminal growth during development and promotes axonal degeneration following injury | |
| Nair‐Gill et al. | Calcium flux control by Pacs1‐Wdr37 promotes lymphocyte quiescence and lymphoproliferative diseases | |
| Hinze et al. | Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis | |
| Edvardson et al. | Infantile neurodegenerative disorder associated with mutations in TBCD, an essential gene in the tubulin heterodimer assembly pathway |